June often brings a mid-year health check, and Europe’s startup ecosystem has delivered one of its own. The data points to a market that is moving again, albeit more cautiously: deal activity is up, while total capital invested is down. At the same time, areas such as digital health, pet care and innovation funding are beginning to reveal shifts that run deeper than a succession of rounds and announcements.

These are the four signals that stood out in June — and what they may tell us about the months ahead.

More activity, but with the brakes still on

In June, Europe’s technology ecosystem recorded 293 deals, up from 258 in May, although total investment fell from €10.5 billion to €8.3 billion, according to tech.eu. The picture is less contradictory than it may seem: more companies are securing funding, but investors are deploying capital more cautiously and demanding clearer evidence of traction, efficiency and execution.

Against this backdrop, Main Capital Partners closed €5.25 billion across two investment vehicles focused on enterprise software. The raise reinforces European private equity’s appetite for B2B businesses with recurring revenues and consolidation potential. Capital remains available, but it is increasingly flowing towards companies that can show how growth will translate into sustainable value.

Digital health enters a more tangible phase

For years, much of the conversation around healthtech has centred on its potential. June’s developments point to a different stage: fewer stand-alone promises and more infrastructure, specialisation and business models built to scale.

CRB Health Tech closed its €50 million Digital Health Tech III fund in June, exceeding its initial target and expanding the pool of specialist capital available to European digital health companies — from diagnostics and digital therapeutics to data integration and healthcare system efficiency. Beyond the headline figure, the close reflects growing interest in companies that have already made progress on clinical, regulatory or commercial validation and now need capital to scale.

Samsung, meanwhile, unveiled its connected care strategy at VivaTech, shifting access to health beyond the hospital and into the home and everyday devices. The proposition illustrates how major technology players are turning the home into a new point of contact with healthcare: more continuous, preventive and integrated into daily routines.

xCures completed a $46 million Series B to structure fragmented medical records. Its case highlights a less visible but decisive issue: artificial intelligence can only generate clinical value when it works with reliable, interoperable information that is ready to support decision-making. In healthcare, organising the data can be just as important as developing the algorithm.

The Pet Economy is becoming more than a consumer category

Spain’s pet care market is evolving from product sales towards recurring services, including veterinary telemedicine, connected devices and subscription models. This shift reflects the increasingly close relationship between people and their pets, as well as growing demand for convenience, prevention and support throughout the animal’s life.

This is where insurance and comprehensive protection plans are beginning to gain ground, combining veterinary assistance, liability cover, care services and even end-of-life solutions. For insurers, clinics and digital platforms, the opportunity lies not only in securing a one-off purchase, but in building an ongoing, trusted relationship with the pet owner.

Public funding becomes a more important part of the growth equation

Spain’s Centre for the Development of Industrial Technology (CDTI) expects to mobilise €1.817 billion in 2026 through instruments such as Neotec, Cervera, Innterconecta-STEP and Innoglobal, aimed at innovative companies and R&D-intensive projects. At a time when private capital is becoming more selective, these mechanisms can provide additional time and room for experimentation while technologies are still being proven.

This public backing does not compete with private capital; it helps reduce technological risk. When the two are combined effectively, startups can move forward with development, validation and expansion without depending on a single source of funding. For Spanish scaleups, that complementarity could become a particularly valuable advantage in the months ahead.

One underlying message behind very different signals

June leaves us with one clear takeaway: capital has not disappeared, but it has become more demanding. Companies that connect a genuine need with a solid business model, reliable data and strong execution will continue to find opportunities. Others will have to navigate longer processes, tighter rounds and increasingly specific questions.

At the same time, connected health, services built around pets and public funding show that innovation does not advance through major headlines alone. Often, the most meaningful shifts begin when new infrastructure and changing habits allow once-emerging models to become part of everyday life.

We will continue to track these signals and how they evolve in the next monthly edition of the GCO Ventures blog.